Skip to main content

Duarte Ira's Form 4 filing

Heron Therapeutics, Inc. (HRTX) · filed Aug 3, 2026

Accession no.
0001193125-26-329720
Filed
Aug 3, 2026, 9:50 AM ET
Trade date
Jul 30-31, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Duarte IraCIK 0001488864Officer (EVP, Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 30, 2026Common StockMOption exerciseAcquired+13,535––277,381Direct
Jul 30, 2026Common StockFTax withholdingDisposed−3,850$0.50−$1,925273,531Direct
Jul 31, 2026Common StockMOption exerciseAcquired+11,694––285,225Direct
Jul 31, 2026Common StockFTax withholdingDisposed−3,326$0.50−$1,663281,899Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 30, 2026Common StockMOption exerciseDisposed−13,535$0.00$0189,492Direct
Jul 31, 2026Common StockMOption exerciseDisposed−11,694$0.00$0116,944Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)